Prenetics Partners and ACON Bio launch Covid-19 antigen kits
Equipment

Prenetics Partners and ACON Bio launch Covid-19 antigen kits

Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy

  • By IPP Bureau | February 27, 2022

The Prenetics Group announced that it has partnered with ACON Bio to launch the Flowflex SARS-CoV-2 Antigen Rapid Test Kit in Hong Kong. The affordable and easy-to-use Covid-19 self-testing solution is the most accurate antigen test kit in the market. FlowFlex is well-equipped with the latest patented technology and provides results in just 15 minutes with 98.8% accuracy.

Flowflex is the most accurate antigen test in the market in both clinical sensitivity and specificity, and also in the detection of Omicron, based on two independent validation studies:

Flowflex is authorized by FDA under a EUA and has the CE Mark for self-testing, is available in more than 100 countries around the world and is used by the National Health Service (NHS) in the United Kingdom as well as by governments and medical associations in the United States, Singapore, Australia, and many more. It is suitable for use in individuals with and without Covid-19 symptoms, and for children as young as two years old.

“We are grateful to partner with ACON Bio, given the urgent need for rapid testing in Hong Kong. With our partnership, we aim to supply millions of testing kits and make it the most affordable FDA EUA authorized rapid test in Hong Kong," said Danny Yeung, CEO and Co-Founder, Prenetics. "By providing near-instant results without the need for specialist equipment or to visit testing facilities, it can provide reassurance before visiting family and friends, particularly those who are more vulnerable."

 

Upcoming E-conference

Other Related stories

Startup

Digitization